SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is surging as investors rally behind its v4 launch and a revenue-sharing model that distributes decentralized GPU network earnings to stakers. The community is heavily focused on the high percentage of supply locked in long-term staking, which is driving intense discussion around potential supply scarcity and the platform's long-term utility in the autonomous agent economy.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a transformative 20-year lease agreement with AI startup Anthropic, which investors view as a pivotal validation of the company's shift from cryptocurrency mining to high-demand AI infrastructure. While the community is actively debating the stock's recent volatility and the impact of the deal, many shareholders remain focused on the potential for long-term growth as TeraWulf scales its data center capacity to meet surging demand.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is currently in the spotlight as investors speculate on a potential buyout given its low valuation compared to competitors, while the company focuses on advancing its lead Phase 3 candidate, HLP003, for major depressive disorder. Community discussion remains polarized, with some focused on the underlying drug's strong intellectual property and breakthrough designation, while others voice significant frustration regarding recent leadership turnover, cash burn concerns, and stock price volatility.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

MUU is trending as investors actively debate the extreme volatility and leveraged decay of the 2x bull ETF amid the broader AI-driven semiconductor rally. While some traders are aggressively buying the dip on the assumption that memory chip demand remains structurally bullish, others are voicing concerns about the rapid price swings and the high risks associated with holding leveraged instruments through market uncertainty.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to the FDA's decision to convene an advisory committee meeting on July 29, an unexpected move that has sparked significant debate within the community regarding its impact on the potential approval of Deramiocel. Investors and stakeholders are actively discussing whether this committee serves as a standard regulatory validation for a first-in-class therapy or reflects deeper concerns, with many viewing the upcoming panel and briefing documents as a crucial catalyst for future price movement.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is drawing intense community focus as investors rotate away from high-flying AI stocks, highlighting the company's strong revenue growth and international expansion despite its recent price pullback. The active discussion centers on its valuation relative to industry leaders, high short interest, and the perceived undervaluation of its Alani Nu brand as a catalyst for a potential recovery.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest and price volatility, fueled by a high short interest of over 40% of the tradable float and expectations of an impending short squeeze. Traders are actively debating the stock's potential for a parabolic move, pointing to tight institutional supply and technical momentum as primary catalysts that could force short-sellers to cover their positions.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending as investors monitor high-profile endorsements and significant government contract wins, while community discussions focus on technical consolidation patterns and the stock's role in the broader AI infrastructure super-cycle. Traders are closely watching institutional accumulation and potential breakout levels, debating whether current price action represents a sustainable trend or headline-driven volatility.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as traders grapple with increased market volatility and a sell-off in semiconductor stocks linked to mixed reactions from international peers like Samsung and SK Hynix. The community remains deeply divided, with many investors debating whether this price action is a short-term manipulation or a deeper correction of the AI-driven rally, while others emphasize the company's strong fundamental outlook and demand for memory chips.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is facing a volatile period as investors weigh the potential impact of hyperscalers like Google and OpenAI diversifying their custom silicon pipelines against the company's long-term strength in AI networking and ASIC infrastructure. While community sentiment remains divided between those viewing recent pullbacks as a strategic buying opportunity and those concerned about peak-cycle exhaustion, the stock continues to be a focal point for institutional accumulation based on its entrenched role in the AI data center buildout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change

Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the Radoff-JEC Group or we), who collectively own approximately 7.7% of the outstanding shares of Seer, Inc. (NASDAQ: SEER) (Seer or the Company), today released a presentation detailing the urgent case for boardroom...

SNTI Shares Surge Over 20% In Pre-Market Trade After FDA RMAT Designation For Cancer Treatment

Equity

Senti Biopharma shares rallied in premarket trading on Tuesday after its cancer treatment received a positive designation from the U.S. FDA.

Senti Biosciences Skyrockets 400% On Oversubscribed PIPE Deal, Promising Cancer Trial Data: Retail Overjoyed

The stock rallied to levels last seen in April 2023, drawing significant attention from retail investors.

This account has been verified as an official SNTI representative.

Verified Account

Senti Biosciences

Operates as a holding company whose subsidiary develops cell and gene therapies for cancer diseases

Senti Biosciences Holdings Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

SNTISenti Biosciences Inc.

Latest SNTI News